Detalhe da pesquisa
1.
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series.
Mol Clin Oncol
; 12(5): 456-460, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32257203